Furthermore, there is clear evidence that GCA patients with cranial ischemic complications (mainly visual ischemic events) have significantly lower inflammatory markers and serum IL-6 levels than GCA patients without ischemic complications. This evidence concerns the gene IL6 and temporal arteritis.